Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | CDC25B | P30305 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15823842 | 1.00 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL12352190 | 1.00 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL60500 | 1.00 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL15303583 | 1.00 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL16542652 | 1.00 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL2045378 | 0.92 | MEN1 (0.41) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL11759426 | 0.91 | MEN1 (0.47) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL12713323 | 0.87 | MEN1 (0.47) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL26633534 | 0.86 | ALOX15 (0.45) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL20778821 | 0.85 | MEN1 (0.44) | MEN1CYP3A4ALOX15KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115785553-A | Crosslinked polyethylene insulated cable | 湖北力生电缆有限公司 | 2023-03-14 | — | — | CN | claimed |
| EP-3649184-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| US-20200070132-A1 | PdIn Alloy Catalyst, Method for Manufacturing PdIn Alloy Catalyst and Application Thereof | ZHEJIANG NHU COMPANY LTD. (CN) | 2020-03-05 | — | — | US | claimed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| WO-2019010265-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| EP-2935176-B1 | (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM (R)-3,7-DIMETYLOCT-6-ENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| EP-2935191-B1 | PREPARATION OF (6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE FROM 3,7-DIMETYLOCT-2-ENAL OR 3,7-DIMETYLOCTA-2,6-DIENAL | DSM IP ASSETS BV (NL) | 2018-08-01 | — | — | EP | claimed |
| US-7411098-B2 | Method for the production of tetrahydrogeranylacetone | BASF SE (DE) | 2008-08-12 | — | — | US | claimed |
| US-20070167655-A1 | Method for the production of tetrahydrogeranylacetone | BASF AKTIENGESELLSCHAFT (DE) | 2007-07-19 | — | — | US | claimed |
| EP-0982282-B1 | Method for producing acetylene alcohol compounds using continuous process | SK CORP (KR) | 2005-01-19 | — | — | EP | claimed |
| EP-0841314-B1 | Catalytic hydrogenation using amorphous metal alloys | HOFFMANN LA ROCHE (CH) | 2003-02-26 | — | — | EP | claimed |
| US-20020183565-A1 | Preparation of higher alpha, beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-05 | — | — | US | claimed |
| EP-1256560-A2 | Process for the preparation of higher alpha,beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-13 | — | — | EP | claimed |
| US-6147266-A | ETHYNYLATION OF KETONES WITH ACETYLENE IN APROTIC SOLVENT IN PRESENCE OF QUATERNARY AMMONIUM HYDROXIDE ANION EXCHANGE RESIN HAVING STRONG BASICITY UNDER MILD CONDITIONS | SK CORPORATION (KR) | 2000-11-14 | — | — | US | claimed |
| CN-1247849-A | Continuous prepn. of acetylene alcohol compound | SK CO LTD (KR) | 2000-03-22 | — | — | CN | claimed |
| EP-0982282-A2 | Method for producing acetylene alcohol compounds using continuous process | SK Corporation (KR) | 2000-03-01 | — | — | EP | claimed |
| US-6002047-A | Catalytic hydrogenation using amorphous metal alloy and a solvent under near-critical or super-critical conditions | ROCHE VITAMINS INC. (US) | 1999-12-14 | — | — | US | claimed |
| WO-2026041681-A1 | SELECTIVE HYDROGENATION OF ALKYNES TO ALKENES USING A NICKEL//PALLADIUM CATALYST | DSM IP ASSETS B.V. (NL) | 2026-02-26 | — | — | WO | disclosed |
| US-3978100-A | Allenic esters, process for preparation thereof and process for rearrangement thereof | KURARAY CO., LTD. (JA) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183565-A1 | Preparation of higher alpha, beta-unsaturated alcohols | ADH1C, CHKB, PDK3 | MEN1 3386/4885CYP3A4 575/4885ALOX15 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.